ResearcherWenzhou Medical UniversityNo recent work listed
Xizhou Lin
Matched on OpenAlex author ID A5000952524. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 2
- Corrigendum to" Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW190… Co-author DOI 10.1016/j.yexmp.2020.104565↗
- The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic… Co-author DOI 10.1016/j.biopha.2017.10.026↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bujian Pan · 2 shared papers, 2017–2021 · strength 0.21
- Paper Corrigendum to" Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and ap… DOI 10.1016/j.yexmp.2020.104565↗
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026↗
- Jun Xiao · 2 shared papers, 2017–2021 · strength 0.21
- Paper Corrigendum to" Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and ap… DOI 10.1016/j.yexmp.2020.104565↗
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026↗
- Haibo Yu · 2 shared papers, 2017–2021 · strength 0.21
- Paper Corrigendum to" Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and ap… DOI 10.1016/j.yexmp.2020.104565↗
- Paper The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transitio… DOI 10.1016/j.biopha.2017.10.026↗
- Wu Ji · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.